(53 days)
Not Found
No
The document describes a dental cement and its properties, with no mention of AI or ML technology.
No
The device is a dental cement used for cementing restorations, which falls under restorative materials rather than for treating or curing a disease or condition.
No
This device is a dental cement used for cementing restorations, not for diagnosing medical conditions.
No
The device description clearly states it is a dual-cure resin cement composed of various materials, indicating it is a physical substance, not software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for the cementation of dental restorations (crowns, bridges, etc.) and posts. This is a direct application within the body (or on a structure that will be placed in the body), not a test performed on a sample taken from the body to diagnose a condition.
- Device Description: The description clearly states it is a "dental cement" and classifies it according to dental regulations (21 CFR section 872.3275). This classification is for devices used in dentistry for restorative purposes, not for diagnostic testing.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples, detecting analytes, or providing diagnostic information.
Therefore, based on the provided text, CLEARFIL SA CEMENT is a dental restorative material, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
-
- Cementation of crowns, bridges, inlays and onlays made of conventional porcelain, ceramic, hybrid ceramics, composite resin or metal
-
- Cementation of metal cores, resin cores, metal posts or glass-fiber posts
Product codes
EMA, KLE
Device Description
-
- CLEARFIL SA CEMENT is a dual-cure (light-and/or self-adhesive resin cement for conventional porcclain, ceramic, hybrid ceramics (e.g. ESTENIA C&B), composite resin and metal restorations.
-
- It is classified into dental cement (21 CFR section 872.3275, Product code: EMA ) according to 21 CFR § 872 since it is composed of various materials other than zinc oxide-eugenol.
-
- According to the applicable FDA recognized consensus standard, ISO 4049: 2000 "Dentistry - Polymer-based filling, restorative and luting materials", this device is classified into the following:
- Class 3: materials that are cured by the application of external energy and also have a self-curing mechanism present
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
CLEARFIL SA CEMENT, the subject device, has been verified to comply with the requirements of the applicable FDA recognized consensus standard, ISO 4049: 2000 "Dentistry - Polymer-based filling, restorative and luting materials". As to comparison with the predicate device, MAXCEM, according to ISO 4049; 2000, it was proved that both the subject one and the predicate one complied with ISO 4049: 2000 and the subject one should be effective as well as the predicate one,
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 872.3275 Dental cement.
(a)
Zinc oxide-eugenol —(1)Identification. Zinc oxide-eugenol is a device composed of zinc oxide-eugenol intended to serve as a temporary tooth filling or as a base cement to affix a temporary tooth filling, to affix dental devices such as crowns or bridges, or to be applied to a tooth to protect the tooth pulp.(2)
Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 872.9.(b)
Dental cement other than zinc oxide-eugenol —(1)Identification. Dental cement other than zinc oxide-eugenol is a device composed of various materials other than zinc oxide-eugenol intended to serve as a temporary tooth filling or as a base cement to affix a temporary tooth filling, to affix dental devices such as crowns or bridges, or to be applied to a tooth to protect the tooth pulp.(2)
Classification. Class II.
0
510(k) Summary
JUL 2 8 2008
3-1. 510(k) owner (submitter)
-
Name
-
Address
-
Contact person
-
Contact person in U.S.
KURARAY MEDICAL INC.
1621 Sakazu, Kurashiki, Okayama 710-0801, Japan
Michio Takigawa Quality Assurance Department
CLEARFIL SA CEMENT
Dental adhesive resin cement
Dental cement
510(k) Number:
21 CFR Section:
Product Code:
Applicant:
Koji Nishida KURARAY AMERICA INC. 600 Lexington Avenue, 26th Floor New York, NY 10022 Tel: (212)-986-2230 (Ext. 115) or (800)-879-1676 Fax: (212)-867-3543
(21 CFR section 872.3275. Product code: EMA)
872.3275
EMA
3-2. Name of Device
-
Trade / Proprietary name
-
Classification name
-
Common name
3-3. Predicate device
-
MAXCEM
-
PANAVIA F 2.0
Applicant: 2) CLEARFIL ESTHETIC CEMENT & DC BOND
510(k) Number: K062410 Product Code: EMA
21 CFR Section: 872. 3275 KURARAY MEDICAL INC.
KURARAY MEDICAL INC.
510(k) Number: Product Code: 21 CFR Section: Applicant:
K041474 EMA 872. 3275 SYBRON DENTAL SPECIALTIES INC.
1
3-4. Device Description
-
- CLEARFIL SA CEMENT is a dual-cure (light-and/or self-adhesive resin cement for conventional porcclain, ceramic, hybrid ceramics (e.g. ESTENIA C&B), composite resin and metal restorations.
-
- It is classified into dental cement (21 CFR section 872.3275, Product code: EMA ) according to 21 CFR § 872 since it is composed of various materials other than zinc oxide-eugenol.
-
- According to the applicable FDA recognized consensus standard, ISO 4049: 2000 "Dentistry - Polymer-based filling, restorative and luting materials", this device is classified into the following:
- Class 3: materials that are cured by the application of external energy and also have a self-curing mechanism present
3-5. Substantial Equivalence Discussion
1) Intended uses
It is intended to be used for the indications listed in the left hand column of the table of "Section 5: Executive Summary, Table 5" that are equivalent to the predicate devices, PANAVIA F2.0 and CLEARFIL ESTHETIC CEMENT & DC BOND.
2) Chemical ingredients / Safety
All the chemical ingredients of CLEARFIL SA CEMENT, the subject device, have been used in the predicate devices, PANAVIA F2.0 and CLEARFIL ESTHETIC CEMENT & DC BOND. It indicates that the safety of the applicant device is substantially equivalent to that of the predicate devices.
3) Effectiveness / Performance
CLEARFIL SA CEMENT, the subject device, has been verified to comply with the requirements of the applicable FDA recognized consensus standard, ISO 4049: 2000 "Dentistry - Polymer-based filling, restorative and luting materials". As to comparison with the predicate device, MAXCEM, according to ISO 4049; 2000, it was proved that both the subject one and the predicate one complied with ISO 4049: 2000 and the subject one should be effective as well as the predicate one,
3-6. Biocompatibility
All the chemical ingredients of CLEARFIL SA CEMENT, the subject device, have been used in the predicate devices as shown on the tables of "Section 7: Substantial Equivalence Discussion, Table: 7-2, 7-3, 7-4" where all the chemical ingredients of the subject device are listed in the left hand column and the abbreviated names of the predicate devices which contain the chemical component are listed in the right hand. From those tables, it can be said that the safety of the subject device is substantially equivalent to the predicate devices.
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized eagle emblem, depicted with flowing lines to represent its wings and body. The eagle faces to the right.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUL 2 8 2008
Kuraray Medical, Incorporated C/O Mr. Koji Nishida General Manager Kuraray America, Incorporated 600 Lexington Avenuc, 26th Floor New York, New York 10022
Re: K081583
Trade/Device Name: CLEARFIL™ SA CEMENT Regulation Number: 872.3275 Regulation Name: Dental Cement Regulatory Class: II Product Code: EMA, KLE Dated: June 3, 2008 Received: June 12, 2008
Dear Mr. Nishida:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2 - Mr. Nishida
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Indications for Use
K 68158 3 510(k) Number (if known):
Device Name: _CLEARFIL SA CEMENT
Indications for Use:
-
- Cementation of crowns, bridges, inlays and onlays made of conventional porcelain, ceramic, hybrid ceramics, composite resin or metal
-
- Cementation of metal cores, resin cores, metal posts or glass-fiber posts
Prescription Use __ (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use __ N/A . (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Susan Reaser
Division Sign-Off) Jivision of Anesthesiology, General Hospital nfection Control, Dental Devices
10(k) Number: